IP Library Granted Patent US 12,121,719
Granted Patent B2
US 12,121,719 · App. 17/480,861 · Granted Oct 22, 2024

Non-invasive neural interface

Inventor: Krishnan Thyagarajan (Mountain View, CA)
Assignee: Xerox Corporation
A61N1/323A61B5/4836A61B5/6801A61B5/6867A61N1/40A61N2/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,121,719
App. No.
17/480,861
Granted
Oct 22, 2024
Kind
B2
Abstract

A neuromodulator includes an electromagnetic (EM) wave generator configured to generate EM waves remote from a patient and to direct the EM waves to one or more target regions within the patient. Frequencies of the EM waves fall outside a range of frequencies that activates neurons. Intersection of the EM waves in each target region creates envelope-modulated electric and magnetic fields having one or more frequencies that fall within the range of frequencies that activates neurons. The neuromodulator includes control circuitry configured to control parameters of the EM waves produced by the EM wave generator. The neuromodulator may use feedback based on one or more of patient input and/or sensing of physiological signals in order to close the loop and control the EM waves.

Claims (36)

1. A system, comprising:

a neuromodulator comprising:

an electromagnetic (EM) wave generator configured to generate EM waves remote from a patient and to direct the EM waves to one or more target regions within the patient, frequencies of the EM waves exceeding a range of frequencies that activates neurons, intersection of the EM waves in each target region creating envelope-modulated electric and magnetic fields having one or more frequencies that fall within the range of frequencies that activates neurons;

a receiver configured to receive a signal responsive to the neuron activation; and

control circuitry configured to control parameters of the EM waves produced by the EM wave generator in response to the received signal.

2. The system of claim 1 , wherein the receiver is configured to receive a physiologic signal responsive to the neuron activation.

3. The system of claim 2 , wherein the physiologic signal comprises one or more of heart rate (HR), blood pressure (BP), respiratory rate (RR), and body temperature.

4. The system of claim 1 , wherein the receiver is configured to receive a neural activity signal sensed from the target region.

5. The system of claim 1 , wherein the receiver is configured to receive a neural activity signal sensed from a second target region different than the target region.

6. The system of claim 1 , wherein the frequencies of the EM waves are greater than about 150 kHz and frequencies of the envelope-modulated electric and magnetic fields are less than about 100 kHz.

7. The system of claim 1 , wherein the control circuitry is configured to control the parameters of the EM waves to change one or more characteristics of the envelope-modulated electrical and magnetic fields in the target regions.

8. The system of claim 7 , wherein:

the parameters that change the characteristics of the envelope-modulated electrical and magnetic fields include frequency, phase, and amplitude; and

the one or more characteristics of the envelope-modulated electrical and magnetic fields include frequency, amplitude, and modulation depth.

9. The system of claim 1 , wherein:

the EM wave generator comprises a phased array configured to generate multiple EM waves; and

the control circuitry is configured to control one or more parameters of the multiple EM waves such that the multiple EM waves undergo constructive and destructive interference that one or both of focuses and steers the multiple EM waves to the target regions.

10. The system of claim 1 , wherein an amplitude of the envelope modulated electric field:

exceeds a threshold for neural activation; or

is below a threshold for activation of neurons within the target region.

11. The system of claim 1 , further comprising communications circuitry configured to transfer patient information from an additional device to the neuromodulation device; and

wherein the control circuitry is configured to modify one or more parameters of the EM waves based on the patient information.

12. The system of claim 11 , wherein the patient information comprises sensed physiological signals.

13. The system of claim 11 , wherein the patient information is based on patient-provided input.

14. A method, comprising:

generating electromagnetic (EM) waves at a location remote from a patient, frequencies of the EM waves exceeding a range of frequencies that activate neurons;

directing the EM waves to one or more target regions within the patient;

intersecting the EM waves in the target regions, in each target region, intersection of the EM waves creating envelope-modulated electrical and magnetic fields having frequencies falling within the range of frequencies that activate neurons;

receiving a signal responsive to the neuron activation; and

controlling parameters of the generated EM waves in response to the received signal.

15. The method of claim 14 , wherein the received signal is a physiologic signal responsive to the neuron activation.

16. The method of claim 15 , wherein the physiologic signal comprises one or more of heart rate (HR), blood pressure (BP), respiratory rate (RR), and body temperature.

17. The method of claim 14 , wherein the received signal is a neural activity signal sensed from the target region.

18. The method of claim 14 wherein the received signal is a neural activity signal sensed from a second target region different than the target region.

19. The method of claim 14 , further comprising controlling one or more parameters of the first and second EM waves to change one or more characteristics of the envelope-modulated electrical and magnetic fields in the target regions.

20. The method of claim 14 , wherein the frequencies of the EM waves are greater than about 150 kHz and frequencies of the envelope-modulated electric and magnetic fields are less than about 100 kHz.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073562/0677 →
SECOND LIEN NOTES PATENT SECURITY AGREEMENT Recorded Jul 2, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071785/0550 →
FIRST LIEN NOTES PATENT SECURITY AGREEMENT Recorded Apr 11, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 070824/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF US PATENTS 9356603, 10026651, 10626048 AND INCLUSION OF US PATENT 7167871 PREVIOUSLY RECORDED ON REEL 064038 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 28, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064161/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064038/0001 →
Continuity (2)
Continuation 16235634 · Dec 28, 2018
Related Publication 20220001173A1 · Jan 6, 2022